Funding for AIDS relief program to stop in coming days after foreign aid pause ordered
The President’s Emergency Plan for AIDS Relief, or PEPFAR, provides billions in funding to organizations to combat HIV.
Related Articles
NSW public to ‘suffer the most’ after mass psychiatrist walkout
New South Wales’ largest mental health care facility has shut its wards following the decision of hundreds of psychiatrists to walk out on their jobs.
Advancing cancer care through digital access in the USA: a state-of-the-art review of patient portals in oncology
Patient portal use among patients with cancer has increased significantly in recent years. This state-of-the-art review seeks to address and analyse literature involving patient portal…
Renal Hypokalemia: An Endocrine Perspective
Abstract. The majority of disorders that cause renal potassium wasting present with abnormalities in adrenal hormone secretion. While these findings freque
Gene copy deletion of STK11, KEAP1, and SMARCA4: clinicopathologic features and association with outcomes to immunotherapy +/- chemotherapy in nonsquamous non-small cell lung cancer
Mutations in STK11, KEAP1, and SMARCA4 predispose to inferior immune checkpoint inhibitor (ICI) efficacy in non-small cell lung cancer (NSCLC), particularly among KRAS-mutant cases. However,…
The process of the Assisted Dying bill is beginning to ring alarm bells
Kim Leadbeater’s reaction to scrutiny and challenge is concerning those who expect an honest debate
A Practical Guide to Autoantibody Testing in Rheumatic Diseases – The Rheumatologist
“ANA’s are some of most commonly ordered tests but what exactly are they and what do you do with a positive ANA? Check out the…
News of the Week – International Academy for Clinical Hematology (IACH)
IACH News of the Week, curated by Dr Edwin Uriel Suárez , is a weekly summary of the latest advancements and discoveries in the field…
CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 − metastatic breast cancer – Cardio-Oncology
Background Cardiovascular (CV) comorbidities and concurrent medications with risk of heart rate-corrected QT interval (QTc) prolongation can impact treatment decisions and safety discussions for patients…
When Trials Find Implausible Results—The SCOT-HEART trial
I would love it if readers can help me explain how a diagnostic test can lead to major reductions in future MIs